Equity Capital Markets

Company · CIK 1478320

Adaptive Biotechnologies Corp

Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26

CIK1478320 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inWA
Business addressWA
ListedADPT (Nasdaq)
First annual or quarterly report2019-08-13

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-239854
ShelfEffective
 2020-07-142020-07-163
333-235989
Registered companyFinal prospectus
 2020-01-212020-01-244
333-231838
IPOFinal prospectus
 2019-05-302019-06-276

Filings

15
FiledFilingRegistrationAccession
2020-07-16424B5Shelf takedown 333-2398540001193125-20-194003
2020-07-14424B5Shelf takedown 333-2398540001193125-20-192670
2020-07-14S-3ASRShelf registered 333-2398540001193125-20-192640
2020-01-24424B4Final prospectus 333-2359890001193125-20-014285
2020-01-23EFFECTDeclared effective 333-2359899999999995-20-000152
2020-01-22S-1/AAmendment 333-2359890001193125-20-012051
2020-01-21S-1Registration filed 333-2359890001193125-20-011067
2020-01-09DRSDraft made public 377-029890000950123-20-000100
2019-06-27424B4Final prospectus 333-2318380001193125-19-184483
2019-06-26EFFECTDeclared effective 333-2318389999999995-19-001450
2019-06-26S-1/AAmendment 333-2318380001193125-19-182012
2019-06-19S-1/AAmendment 333-2318380001193125-19-176598
2019-06-17S-1/AAmendment 333-2318380001193125-19-174174
2019-05-30S-1Registration filed 333-2318380001193125-19-161447
2019-03-29DRSDraft made public 377-025640000950123-19-002935

All filings of this company · CSV